Categories AlphaGraphs, Health Care

Graphic: How Quest Diagnostics (DGX) performed in Q2 2020

Quest Diagnostics (NYSE: DGX) reported second-quarter financial results before the regular market hours on Thursday. The Q2 earnings were a cent higher than the average Wall Street prediction, while the revenues were in line.

DGX shares fell 1.8% immediately following the announcement. The stock has gained 23% since the beginning of the year.  

Quest Diagnostics Q2 2020 earnings

Looking forward to listening to management/ analysts comments on Q2 results? Stay tuned here for Quest Diagnostics Q2 2020 earnings call transcript

CEO Steve Rusckowski said, “Looking forward to the rest of the year, we will continue to expand COVID-19 testing capacity while also continuing to serve our customers as they continue to recover from the pandemic.”

Prior performance

[irp posts=”66899″]

Most Popular

Aurora Cannabis (ACB) Earnings: 3Q21 Key Numbers

Aurora Cannabis Inc. (NYSE: ACB) reported third quarter 2021 earnings results today. Total revenues fell 25% year-over-year to CAD55.1 million. Adjusted EBITDA loss amounted to CAD24 million. Cash balance as

Walt Disney (DIS) Q2 revenue down 13%; earnings beat estimates

Media behemoth The Walt Disney Company (NYSE: DIS) reported second-quarter revenues that declined from last year as customers stayed away from theatres and parks due to pandemic-related safety issues and

Three key factors that bode well for Tattooed Chef (TTCF) going forward

Shares of Tattooed Chef Inc. (NASDAQ: TTCF) have gained 57% over the past 12 months but has dropped 25% since the start of this year. The sentiment on the stock

Add Comment
Viewing Highlight